KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Non-Current Debt (2016 - 2026)

West Pharmaceutical Services has reported Non-Current Debt over the past 18 years, most recently at $202.8 million for Q1 2026.

  • Quarterly Non-Current Debt changed 0.1% to $202.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $202.8 million through Mar 2026, changed 0.1% year-over-year, with the annual reading at $202.8 million for FY2025, 0.1% changed from the prior year.
  • Non-Current Debt was $202.8 million for Q1 2026 at West Pharmaceutical Services, roughly flat from $202.8 million in the prior quarter.
  • Over five years, Non-Current Debt peaked at $208.3 million in Q1 2022 and troughed at $72.8 million in Q4 2023.
  • The 5-year median for Non-Current Debt is $202.7 million (2025), against an average of $178.3 million.
  • Biggest five-year swings in Non-Current Debt: tumbled 64.78% in 2023 and later skyrocketed 178.3% in 2024.
  • Tracing WST's Non-Current Debt over 5 years: stood at $206.7 million in 2022, then tumbled by 64.78% to $72.8 million in 2023, then skyrocketed by 178.3% to $202.6 million in 2024, then grew by 0.1% to $202.8 million in 2025, then changed by 0.0% to $202.8 million in 2026.
  • According to Business Quant data, Non-Current Debt over the past three periods came in at $202.8 million, $202.8 million, and $202.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.